Life insurance growth remained subdued in H1, while health and non-motor business supported gains in the non-life sector amid sweeping regulatory changes.
Aggressive pricing and weak solvency among several state-owned insurers could test India's insurance growth story despite favourable regulatory reforms, S&P says.
The country's three major non-life groups remain well capitalised after FYE26 earnings were supported by divestment proceeds and better pricing in domestic motor and property lines.
Insurers across China, Taiwan and South Korea are bolstering capital buffers and refining investment strategies as low rates and volatility strain traditional earnings models.
A prolonged low-rate environment is forcing Chinese insurers to rethink product design, with participating policies emerging as a core strategic and credit-supportive pillar.
With alternative investment yields fading and bond returns under pressure, insurers are reshaping portfolios and leaning on capital markets, increasing vulnerability to earnings shocks.
